97 related articles for article (PubMed ID: 7624154)
1. The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential.
Tsuda T; Marinetti MR; Masuelli L; Cutler ML
Oncogene; 1995 Jul; 11(2):397-403. PubMed ID: 7624154
[TBL] [Abstract][Full Text] [Related]
2. Expression of LRRC4 has the potential to decrease the growth rate and tumorigenesis of glioblastoma cell line U251.
Wang JR; Li XL; Fan SQ; Tan C; Xiang JJ; Tang K; Wang R; Li GY
Ai Zheng; 2003 Sep; 22(9):897-902. PubMed ID: 12969517
[TBL] [Abstract][Full Text] [Related]
3. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions.
Dougherty GW; Chopp T; Qi SM; Cutler ML
Exp Cell Res; 2005 May; 306(1):168-79. PubMed ID: 15878342
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the functional role of chromosome 10 loss in human glioblastomas.
Pershouse MA; Stubblefield E; Hadi A; Killary AM; Yung WK; Steck PA
Cancer Res; 1993 Oct; 53(20):5043-50. PubMed ID: 8104691
[TBL] [Abstract][Full Text] [Related]
5. The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression.
Masuelli L; Ettenberg S; Vasaturo F; Vestergaard-Sykes K; Cutler ML
Cell Growth Differ; 1999 Aug; 10(8):555-64. PubMed ID: 10470855
[TBL] [Abstract][Full Text] [Related]
6. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells.
Wechsler DS; Shelly CA; Petroff CA; Dang CV
Cancer Res; 1997 Nov; 57(21):4905-12. PubMed ID: 9354456
[TBL] [Abstract][Full Text] [Related]
7. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43).
Huang RP; Fan Y; Hossain MZ; Peng A; Zeng ZL; Boynton AL
Cancer Res; 1998 Nov; 58(22):5089-96. PubMed ID: 9823317
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
10. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
11. Suppression of transformed phenotype and tumorigenicity after transfer of chromosome 4 into U251 human glioma cells.
Pershouse MA; Ligon AH; Pereira-Smith OM; Killary AM; Yung WK; Steck PA
Genes Chromosomes Cancer; 1997 Nov; 20(3):260-7. PubMed ID: 9365833
[TBL] [Abstract][Full Text] [Related]
12. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
13. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor gene WT1 inhibits ras-mediated transformation.
Luo XN; Reddy JC; Yeyati PL; Idris AH; Hosono S; Haber DA; Licht JD; Atweh GF
Oncogene; 1995 Aug; 11(4):743-50. PubMed ID: 7651738
[TBL] [Abstract][Full Text] [Related]
16. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
17. [Function of a novel brain-specific gene LRRC4].
Fan SQ; Wang JR; Huang H; Xiong W; Xiao BY; Ou YJ; Cao L; Tan C; Li GY
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):393-6. PubMed ID: 16188120
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.
Sato KY; Polakis PG; Haubruck H; Fasching CL; McCormick F; Stanbridge EJ
Cancer Res; 1994 Jan; 54(2):552-9. PubMed ID: 8275494
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
